Management of the patient with a malignant pleural effusion

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 6, 2010, Pages 723-733

  Heffner, John E ^a,b  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cancer; Malignant pleural effusion; pleural disease; pleurodesis

Indexed keywords

SCLEROSING AGENT;

ARTICLE; CLINICAL PRACTICE; HUMAN; PALLIATIVE THERAPY; PATIENT CARE; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; RISK FACTOR;

AMBULATORY CARE; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASM STAGING; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; QUALITY OF LIFE; SURVIVAL RATE;

EID: 78651088593     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1269831     Document Type: Article

References (139)

1. Heffner J E., Nietert P J., Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000 117 79-86
2. Gonzalez A V., Bezwada V, Beamis JFJ Jr, Villanueva A G. Lung injury following thoracoscopic talc insufflation: experience of a single North American center. Chest 2010 137 1375-1381
3. Goldstraw P, Crowley J, Chansky K et al, International Association for the Study of Lung Cancer International Staging Committee Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007 2 706-714 (Pubitemid 47357522)
4. Heffner J E. Diagnosis and management of malignant pleural effusions. Respirology 2008 13 5-20
5. Kolschmann S, Ballin A, Gillissen A. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 2005 128 1431-1435
6. Rubio E R., Chang E E., Kovitz K L. Thoracoscopic management of pleural effusions in Kaposi's sarcoma: a rapid and effective alternative for diagnosis and treatment. South Med J 2002 95 919-921
7. Fujita A, Takabatake H, Tagaki S, Sekine K. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer: cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support. Chest 2001 119 340-343
8. Matsumoto Y, Nomura K, Ueda K et al. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 2005 46 415-419
9. Das S K., Saha S K., Das A, Halder A K., Banerjee S N., Chakraborty M. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions. J Indian Med Assoc 2008 106 589-590, 592
10. Dresler C M., Olak J, Herndon J E. II et al, Cooperative Groups Cancer and Leukemia Group B Eastern Cooperative Oncology Group North Central Cooperative Oncology Group Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005 127 909-915
11. Ozyurtkan M O., Balci A E., Cakmak M. Predictors of mortality within three months in the patients with malignant pleural effusion. Eur J Intern Med 2010 21 30-34
12. Das D K. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006 34 335-347
13. Villena V, Pérez V, Pozo F et al. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. Chest 2002 121 470-474
14. Bielsa S, Salud A, Martínez M et al. Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med 2008 19 334-339
15. Bielsa S, Esquerda A, Salud A et al. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions. Eur J Intern Med 2009 20 383-386
16. Jiménez D, Díaz G, Gil D et al. Etiology and prognostic significance of massive pleural effusions. Respir Med 2005 99 1183-1187
17. Duysinx B, Corhay J L., Larock M P. et al. Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion. Nucl Med Commun 2008 29 982-986
18. Burrows C M., Mathews W C., Colt H G. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000 117 73-78
19. Bernard A, de Dompsure R B., Hagry O, Favre J P. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002 74 213-217
20. Steger V, Mika U, Toomes H et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg 2007 83 1940-1945
21. Heidecker J, Huggins J T., Sahn S A., Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 2006 130 (4) 1173-1184
22. Ponrartana S, Laberge J M., Kerlan R K., Wilson M W., Gordon R L. Management of patients with ex vacuo pneumothorax after thoracentesis. Acad Radiol 2005 12 980-986
23. Feller-Kopman D. Therapeutic thoracentesis: the role of ultrasound and pleural manometry. Curr Opin Pulm Med 2007 13 312-318
24. Huggins J T., Sahn S A., Heidecker J, Ravenel J G., Doelken P. Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest 2007 131 206-213
25. Heffner J E., Nietert P J., Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data. Chest 2000 117 87-95
26. Heffner J E., Heffner J N., Brown L K. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 2003 123 1887-1894
27. Crnjac A, Sok M, Kamenik M. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur J Cardiothorac Surg 2004 26 432-436
28. Antunes G, Neville E, Duffy J, Ali N, Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of malignant pleural effusions. Thorax 2003 58 (Suppl 2) ii29-ii38
29. Marrazzo A, Noto A, Casà L et al. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J Pain Symptom Manage 2005 30 75-79
30. Barnes T W., Morgenthaler T I., Olson E J., Hesley G K., Decker P A., Ryu J H. Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound 2005 33 442-446
31. Huggins J T., Doelken P. Pleural manometry. Clin Chest Med 2006 27 229-240
32. Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracentesis. Chest 2006 129 1556-1560
33. Maskell N A., Butland R J., Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003 58 (Suppl 2) ii8-ii17
34. Lee Y C., Baumann M H., Maskell N A. et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003 124 2229-2238
35. Medford A R., Maskell N A. A national survey of oncologist and chest physicians' attitudes towards empirical anti-oestrogen therapy, early pleurodesis and preference of sclerosing agent in malignant breast and ovarian pleural disease. Palliat Med 2005 19 430-431
36. Saffran L, Ost D E., Fein A M., Schiff M J. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000 118 417-421
37. Sartori S, Tombesi P, Tassinari D et al. Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions. J Ultrasound Med 2004 23 1171-1176
38. Caglayan B, Torun E, Turan D et al. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann Surg Oncol 2008 15 2594-2599
39. Spiegler P A., Hurewitz A N., Groth M L. Rapid pleurodesis for malignant pleural effusions. Chest 2003 123 1895-1898
40. Yildirim E, Dural K, Yazkan R et al. Rapid pleurodesis in symptomatic malignant pleural effusion. Eur J Cardiothorac Surg 2005 27 19-22
41. Marom E M., Erasmus J J., Herndon J E. II, Zhang C, McAdams H P. Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. AJR Am J Roentgenol 2002 179 105-108
42. Terra R M., Junqueira J J., Teixeira L R., Vargas F S., Pêgo-Fernandes P M., Jatene F B. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis? Chest 2009 136 361-368
43. Mager H J., Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002 36 77-81
44. Dryzer S R., Allen M L., Strange C, Sahn S A. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 1993 104 1763-1766
45. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006 29 829-838
46. Teixeira L R., Vargas F S., Acencio M M. et al. Influence of antiinflammatory drugs (methylprednisolone and diclofenac sodium) on experimental pleurodesis induced by silver nitrate or talc. Chest 2005 128 4041-4045
47. Teixeira L R., Wu W, Chang D S., Light R W. The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits. Chest 2002 121 216-219
48. Xie C, Teixeira L R., McGovern J P., Light R W. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med 1998 157 (5 Pt 1) 1441-1444
49. Haddad F J., Younes R N., Gross J L., Deheinzelin D. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg 2004 28 749-753, discussion 753-754
50. Goodman A, Davies C W. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 2006 54 51-55
51. Arapis K, Caliandro R, Stern J B., Girard P, Debrosse D, Gossot D. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc 2006 20 919-923
52. Brega-Massone P P., Lequaglie C, Magnani B, Ferro F, Cataldo I. Chemical pleurodesis to improve patients' quality of life in the management of malignant pleural effusions: the 15 year experience of the National Cancer Institute of Milan. Surg Laparosc Endosc Percutan Tech 2004 14 73-79
53. Cardillo G, Facciolo F, Carbone L et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002 21 302-305, discussion 305-306
54. Crnjac A. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions. Wien Klin Wochenschr 2004 116 (Suppl 2) 28-32 (Pubitemid 38979925)
55. Debeljak A, Kecelj P, Triller N et al. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions. J BUON 2006 11 463-467
56. Gasparri R, Leo F, Veronesi G et al. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 2006 106 271-276
57. Trotter D, Aly A, Siu L, Knight S. Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital's experience. Heart Lung Circ 2005 14 93-97
58. Casal R F., Eapen G A., Morice R C., Jimenez C A. Medical thoracoscopy. Curr Opin Pulm Med 2009 15 313-320
59. Law W L., Chan J W., Lee S et al. Pleuroscopy: our initial experience in Hong Kong. Hong Kong Med J 2008 14 178-184
60. Lee P, Colt H G. Rigid and semirigid pleuroscopy: the future is bright. Respirology 2005 10 418-425
61. Ernst A, Hersh C P., Herth F et al. A novel instrument for the evaluation of the pleural space: an experience in 34 patients. Chest 2002 122 1530-1534
62. Munavvar M, Khan M A., Edwards J, Waqaruddin Z, Mills J. The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur Respir J 2007 29 571-574
63. Katlic M R. Video-assisted thoracic surgery utilizing local anesthesia and sedation. Eur J Cardiothorac Surg 2006 30 529-532
64. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004 (1) CD002916
65. Schulze M, Boehle A S., Kurdow R, Dohrmann P, Henne-Bruns D. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001 71 1809-1812
66. Ukale V, Agrenius V, Hillerdal G, Mohlkert D, Widström O. Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug. Lung Cancer 2004 43 323-328
67. Paschoalini MdaS, Vargas F S., Marchi E et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 2005 128 684-689
68. Kuzdza J, Sadek K, Wasowski D et al. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. Med Sci Monit 2003 9 PI54-PI59
69. Ong K C., Indumathi V, Raghuram J, Ong Y Y. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000 5 99-103
70. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001 6 181-185
71. de Campos J R., Vargas F S., de Campos Werebe E et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001 119 801-806
72. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984 86 795-797
73. Peek H, van der Bruggen W, Limonard G. Pleural FDG uptake more than a decade after talc pleurodesis. Case Report Med 2009 2009 650864
74. Ahmadzadehfar H, Palmedo H, Strunk H, Biersack H J., Habibi E, Ezziddin S. False positive 18F-FDG-PET/CT in a patient after talc pleurodesis. Lung Cancer 2007 58 418-421
75. Ferrer J, Montes J F., Villarino M A., Light R W., García-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002 122 1018-1027
76. Froudarakis M E., Klimathianaki M, Pougounias M. Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest 2006 129 356-361
77. Rossi V F., Vargas F S., Marchi E et al. Acute inflammatory response secondary to intrapleural administration of two types of talc. Eur Respir J 2010 35 396-401
78. Viallat J R., Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions: a review of 360 cases. Chest 1996 110 1387-1393
79. Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993 106 689-695
80. Noppen M. Who's (still) afraid of talc? Eur Respir J 2007 29 619-621
81. Janssen J P., Collier G, Astoul P et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007 369 1535-1539
82. Kuzniar T J., Blum M G., Kasibowska-Kuzniar K, Mutlu G M. Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann Thorac Surg 2006 82 1976-1981
83. Dikensoy O, Light R W. Alternative widely available, inexpensive agents for pleurodesis. Curr Opin Pulm Med 2005 11 340-344
84. van den Toorn L M., Schaap E, Surmont V F., Pouw E M., van der Rijt K C., van Klaveren R J. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 2005 50 123-127
85. Putnam J B. Jr, Light R W., Rodriguez R M. et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999 86 1992-1999
86. Putnam J B. Jr, Walsh G L., Swisher S G. et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000 69 369-375
87. Pollak J S., Burdge C M., Rosenblatt M, Houston J P., Hwu W J., Murren J. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 2001 12 201-208
88. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006 129 362-368
89. Pien G W., Gant M J., Washam C L., Sterman D H. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001 119 1641-1646
90. Musani A I., Haas A R., Seijo L, Wilby M, Sterman D H. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004 71 559-566
91. Ohm C, Park D, Vogen M et al. Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions. Am Surg 2003 69 198-202, discussion 202
92. Sioris T, Sihvo E, Salo J, Räsänen J, Knuuttila A. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis. Eur J Surg Oncol 2009 35 546-551
93. Spector M, Pollak J S. Management of malignant pleural effusions. Semin Respir Crit Care Med 2008 29 405-413
94. Thornton R H., Miller Z, Covey A M. et al. Tunneled pleural catheters for treatment of recurrent malignant pleural effusion following failed pleurodesis. J Vasc Interv Radiol 2010 21 696-700
95. Efthymiou C A., Masudi T, Thorpe J A., Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung: five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg 2009 9 961-964
96. Warren W H., Kim A W., Liptay M J. Identification of clinical factors predicting PleurX catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg 2008 33 89-94
97. Warren W H., Kim A W., Liptay M J. Identification of clinical factors predicting PleurX catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg 2008 33 89-94
98. Pollak J S. Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med 2002 8 302-307
99. Murthy S C., Okereke I, Mason D P., Rice T W. A simple solution for complicated pleural effusions. J Thorac Oncol 2006 1 697-700
100. Warren W. Talc pleurodesis for malignant pleural effusions is preferred over the PleurX catheter (contrary position). Ann Surg Oncol 2007 14 2700-2701
101. Stather D R., Tremblay A. Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions. Curr Opin Pulm Med 2007 13 328-333 (Pubitemid 46847300)
102. Bazerbashi S, Villaquiran J, Awan M Y., Unsworth-White M J., Rahamim J, Marchbank A. Ambulatory intercostal drainage for the management of malignant pleural effusion: a single center experience. Ann Surg Oncol 2009 16 3482-3487
103. Olden A M., Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med 2010 13 59-65
104. Antevil J L., Putnam JBJ Jr. Talc pleurodesis for malignant effusions is preferred over the pleurx catheter (pro position). Ann Surg Oncol 2007 14 2698-2699
105. Wachsman A M., Hoffer E K., Forauer A R., Silas A M., Gemery J M. Tension pneumothorax after placement of a tunneled pleural drainage catheter in a patient with recurrent malignant pleural effusions. Cardiovasc Intervent Radiol 2007 30 531-533
106. Janes S M., Rahman N M., Davies R J., Lee Y C. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007 131 1232-1234
107. Genc O, Petrou M, Ladas G, Goldstraw P. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 2000 18 143-146
108. Artemiou O, Marta G M., Klepetko W, Wolner E, Müller M R. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann Thorac Surg 2003 76 231-233
109. American Academy of Hospice and Palliative Medicine Center to Advance Palliative Care Hospice and Palliative Nurses Association Last Acts Partnership National Hospice and Palliative Care Organization. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for quality palliative care, executive summary. J Palliat Med 2004 7 611-627
110. Word Health Organization definition of palliative care. World Health Organization programmes and projects (online). 2010. Available at: http://www.who.int/cancer/palliative/definition/en/ Accessed November 17, 2010
111. Kilic D, Akay H, Kavukçu S et al. Management of recurrent malignant pleural effusion with chemical pleurodesis. Surg Today 2005 35 634-638
112. Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion: a prospective comparative study. Eur J Cardiothorac Surg 2006 30 827-832
113. Porcel J M., Salud A, Nabal M, Vives M, Esquerda A, Rodríguez- Panadero F. Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions. Support Care Cancer 2006 14 475-478
114. Heffner J E., Standerfer R J., Torstveit J, Unruh L. Clinical efficacy of doxycycline for pleurodesis. Chest 1994 105 1743-1747
115. Sartori S, Tassinari D, Ceccotti P et al. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions. J Clin Oncol 2004 22 1228-1233
116. Moffett M J., Ruckdeschel J C. Bleomycin and tetracycline in malignant pleural effusions: a review. Semin Oncol 1992 19 (2, Suppl 5) 59-62, discussion 62-63
117. Stiksa G, Korsgaard R, Simonsson B G. Treatment of recurrent pleural effusion by pleurodesis with quinacrine: comparison between instillation by repeated thoracenteses and by tube drainage. Scand J Respir Dis 1979 60 197-205
118. Bayly T C., Kisner D L., Sybert A, Macdonald J S., Tsou E, Schein P S. Tetracycline and quinacrine in the control of malignant pleural effusions: a randomized trial. Cancer 1978 41 1188-1192
119. Koldsland S, Svennevig J L., Lehne G, Johnson E. Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin. Thorax 1993 48 790-793
120. Banerjee A K., Willetts I, Robertson J F., Blamey R W. Pleural effusion in breast cancer: a review of the Nottingham experience. Eur J Surg Oncol 1994 20 33-36
121. Olivares-Torres C A., Laniado-Laborín R, Chávez- García C, León-Gastelum C, Reyes-Escamilla A, Light R W. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002 122 581-583
122. Agarwal R, Aggarwal A N., Gupta D. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 2006 11 105-108
123. Agarwal R, Aggarwal A N., Gupta D, Jindal S K. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir Med 2006 100 2043-2047
124. Kelly-Garcia J, Roman-Berumen J F., Ibarra-Perez C. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Arch Med Res 1997 28 583-585
125. Agarwal R. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis. Lung Cancer 2007 55 253-254
126. Dey A, Bhuniya S, Datta Chaudhuri A et al. Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata. Singapore Med J 2010 51 163-165
127. Foresti V. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions. Respiration 1995 62 21-26
128. Hillerdal G, Kiviloog J, Nöu E, Steinholtz L. Corynebacterium parvum in malignant pleural effusion: a randomized prospective study. Eur J Respir Dis 1986 69 204-206
129. McLeod D T., Calverley P M., Millar J W., Horne N W. Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax 1985 40 515-518
130. Senyiit A, Bayram H, Babayiit C, Topçu F, Balci A E., Satici O. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases. Respiration 2000 67 623-629
131. Chella A, Ribechini A, Dini P, Adamo C, Mussi A, Angeletti C A. Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis. [in Italian] Minerva Chir 1994 49 (11) 1077-1082
132. Barbetakis N, Antoniadis T, Tsilikas C. Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer. World J Surg Oncol 2004 2 16
133. Barbetakis N, Vassiliadis M, Kaplanis K, Valeri R, Tsilikas C. Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer. BMC Palliat Care 2004 3 4
134. Kelly J, Holmes E C., Rosen G. Mitoxantrone for malignant pleural effusion due to metastatic sarcoma. Surg Oncol 1993 2 299-301
135. Wilkins H E. III, Connolly M M., Grays P, Marquez G, Nelson D. Recombinant interferon alpha-2b in the management of malignant pleural effusions. Chest 1997 111 1597-1599
136. Sartori S, Trevisani L, Nielsen I, Tassinari D, Abbasciano V. Intracavitary bleomycin vs interferon in the management of malignant pleural effusions. Chest 1998 113 1145-1146
137. Ren S, Terman D S., Bohach G et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 2004 126 1529-1539
138. Kasahara K, Shibata K, Shintani H et al. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer. Anticancer Res 2006 26 1495-1499
139. Luh K T., Yang P C., Kuo S H., Chang D B., Yu C J., Lee L N. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992 69 674-679